JP2017137323A5 - - Google Patents

Download PDF

Info

Publication number
JP2017137323A5
JP2017137323A5 JP2017037462A JP2017037462A JP2017137323A5 JP 2017137323 A5 JP2017137323 A5 JP 2017137323A5 JP 2017037462 A JP2017037462 A JP 2017037462A JP 2017037462 A JP2017037462 A JP 2017037462A JP 2017137323 A5 JP2017137323 A5 JP 2017137323A5
Authority
JP
Japan
Prior art keywords
group
alkyl
formula
pharmaceutically acceptable
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017037462A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017137323A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017137323A publication Critical patent/JP2017137323A/ja
Publication of JP2017137323A5 publication Critical patent/JP2017137323A5/ja
Pending legal-status Critical Current

Links

JP2017037462A 2010-10-27 2017-02-28 新規抗がん剤 Pending JP2017137323A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40726510P 2010-10-27 2010-10-27
US61/407,265 2010-10-27

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2013535207A Division JP6184866B2 (ja) 2010-10-27 2011-10-27 新規抗がん剤

Publications (2)

Publication Number Publication Date
JP2017137323A JP2017137323A (ja) 2017-08-10
JP2017137323A5 true JP2017137323A5 (enExample) 2017-09-21

Family

ID=45992970

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013535207A Expired - Fee Related JP6184866B2 (ja) 2010-10-27 2011-10-27 新規抗がん剤
JP2017037462A Pending JP2017137323A (ja) 2010-10-27 2017-02-28 新規抗がん剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2013535207A Expired - Fee Related JP6184866B2 (ja) 2010-10-27 2011-10-27 新規抗がん剤

Country Status (12)

Country Link
US (3) US8835629B2 (enExample)
EP (1) EP2632916B1 (enExample)
JP (2) JP6184866B2 (enExample)
KR (1) KR101896924B1 (enExample)
CN (1) CN103476769B (enExample)
AU (1) AU2011320024B2 (enExample)
CA (1) CA2814120C (enExample)
ES (1) ES2621932T3 (enExample)
HU (1) HUE032522T2 (enExample)
NZ (1) NZ609186A (enExample)
PL (1) PL2632916T3 (enExample)
WO (1) WO2012054978A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2814120C (en) * 2010-10-27 2018-08-07 The Walter And Eliza Hall Institute Of Medical Research Novel anti-cancer agents
KR101853785B1 (ko) 2013-11-20 2018-05-02 주식회사 만도 3상모터 제어장치 및 그의 고토크 유지 방법
WO2016070241A1 (en) * 2014-11-03 2016-05-12 Ctxt Pty Ltd Triazine compounds, compositions and synthesis
WO2018226923A1 (en) * 2017-06-08 2018-12-13 University Of South Alabama Antimicrobial compounds
CU24661B1 (es) 2018-01-17 2023-05-11 Aurigene Discovery Tech Ltd Compuestos de alquinileno sustituidos como agentes anticancerígenos

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2742466A (en) 1956-04-17 Chx n nhx c c
GB1035771A (enExample)
US3145203A (en) 1961-11-30 1964-08-18 Geigy Chem Corp Hydrazones of 5-nitro-2-furaldehyde
JPS5277163A (en) 1975-12-24 1977-06-29 Asahi Chem Ind Co Ltd Stabilized polyurethane composition
FR2524467A1 (fr) 1982-03-30 1983-10-07 Adir Polymethylene-imines disubstituees, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
JPS62192474A (ja) 1986-02-19 1987-08-24 Canon Inc 記録液
US4932998A (en) 1986-09-30 1990-06-12 Idemitsu Kosan Company Limited Triazine derivatives, and herbicides comprising the same as the effective ingredient
US4844731A (en) 1986-12-27 1989-07-04 Idemitsu Company Co., Ltd. Triazine derivatives
US5187045A (en) 1988-09-07 1993-02-16 Minnesota Mining And Manufacturing Company Halomethyl-1,3,5-triazines containing a sensitizer moiety
ES2094150T3 (es) 1989-02-20 1997-01-16 Idemitsu Kosan Co Derivado de triazina y herbicida que lo contiene a titulo de ingrediente activo.
CA2123402A1 (en) 1991-11-12 1993-05-27 Jotham W. Coe Triazine derivatives for enhancing antitumor activity
AU665238B2 (en) 1992-02-28 1995-12-21 Zenyaku Kogyo Kabushiki Kaisha S-triazine derivative and remedy for estrogen-dependent diseases containing the same as active ingredient
US5574057A (en) * 1993-02-03 1996-11-12 University Of Utah Research Foundation Naamidine A extracted from sea sponges and methods for its use as an anti-tumor agent
US6566384B1 (en) 1996-08-07 2003-05-20 Darwin Discovery Ltd. Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity
FR2757056B1 (fr) 1996-12-17 2003-03-14 Oreal Compositions comprenant un derive de dibenzoylmethane, un derive de 1,3,5-triazine et un compose amide et utilisations
FR2757057A1 (fr) 1996-12-17 1998-06-19 Oreal Compositions comprenant un derive de dibenzoylmethane, un derive de 1,3,5-triazine et un derive silicie a fonction benzalmalonate et utilisations
EP0945447A1 (en) 1998-03-27 1999-09-29 Janssen Pharmaceutica N.V. Trisubstituted 1,3,5-triazine derivatives for treatment of HIV infections
US6262053B1 (en) 1999-06-23 2001-07-17 Parker Hughes Institute Melamine derivatives as potent anti-cancer agents
IL155367A0 (en) * 2000-10-23 2003-12-23 Smithkline Beecham Corp NOVEL 2,4,8-TRISUBSTITUTED-8h-PYRIDO[2,3,-d]PYRIMIDIN-7-ONE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, PROCESSES FOR THE PREPARATION THEREOF, AND USE THEREOF IN THE PREPARATION OF MEDICAMENTS FOR TREATING CSBP/p38 KINASE MEDIATED DISEASES
US7173032B2 (en) * 2001-09-21 2007-02-06 Reddy Us Therapeutics, Inc. Methods and compositions of novel triazine compounds
EP1441683A4 (en) 2001-10-12 2005-10-26 Univ New York TRISUBSTITUTED TRIAZIN COMPOUNDS AND METHOD FOR THE PREPARATION AND USE OF THE COMPOUNDS WITH ANTITUBULIN EFFECT
CN1697831A (zh) * 2002-09-23 2005-11-16 雷迪美国治疗公司 新三嗪化合物的制备方法和组合物
CA2814120C (en) * 2010-10-27 2018-08-07 The Walter And Eliza Hall Institute Of Medical Research Novel anti-cancer agents

Similar Documents

Publication Publication Date Title
JP2017137323A5 (enExample)
RU2477723C2 (ru) Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе
JP2016506958A5 (enExample)
JP2016503799A5 (enExample)
JP2016518328A5 (enExample)
JP2016531126A5 (enExample)
JP2013537203A5 (enExample)
CY1120248T1 (el) Ενωσεις ιμιδαζο[4,5-c]κινολιν-2-ονης και η χρηση τους στη θεραπευτικη αντιμετωπιση του καρκινου
JP2016503414A5 (enExample)
JP2016515561A5 (enExample)
CN107548391A (zh) 嘧啶或吡啶类化合物、其制备方法和医药用途
JP2017504635A5 (enExample)
JP2014521688A5 (enExample)
RU2016134751A (ru) Соединения
JP2016505614A5 (enExample)
JP2016537382A5 (enExample)
CY1118572T1 (el) Παραγωγο κυκλοαλκανιου
JP2015537020A5 (enExample)
JP2014504622A5 (enExample)
JP2015520143A5 (enExample)
JP2016513137A5 (enExample)
JP2019500315A5 (enExample)
JP2015518899A5 (enExample)
JP2014526533A5 (enExample)
JP2017501237A5 (enExample)